Japan Tissue Engineering Co., Ltd. (JP:7774) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Japan Tissue Engineering Co., Ltd. reported a decline in net sales and net income for the second quarter of FY2024 compared to the previous year, with net sales down by 6.8% and net income per share falling to -5.55 yen. Despite these setbacks, the company maintains a strong equity ratio of 90.3%, indicating financial stability. Looking ahead, the company forecasts a modest recovery in net sales and income for the full fiscal year, although net income is expected to decrease by 39.2% compared to the previous year.
For further insights into JP:7774 stock, check out TipRanks’ Stock Analysis page.